Replies to post #11123 on Humanigen Inc (fka HGENQ)

[Fezziwig2008]

“We are thrilled that NIH selected lenzilumab to be part of its Big Effect Trial,” said Cameron Durrant, MD, MBA, chief executive officer of Humanigen. “With data from the BET and our ongoing Phase III study, we will have data from approximately 500 hospitalized COVID-19 patients.” Locked and loaded.